Review



rfp eea1  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Addgene inc rfp eea1
    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker <t>RFP-EEA1</t> and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).
    Rfp Eea1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rfp+eea1/pmc11850004-253-0-21?v=Addgene+inc
    Average 93 stars, based on 27 article reviews
    rfp eea1 - by Bioz Stars, 2026-07
    93/100 stars

    Images

    1) Product Images from "Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration"

    Article Title: Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration

    Journal: eLife

    doi: 10.7554/eLife.99373

    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker RFP-EEA1 and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).
    Figure Legend Snippet: ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker RFP-EEA1 and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).

    Techniques Used: Activation Assay, Expressing, Control, Bioluminescence Resonance Energy Transfer, Marker, Transfection, Confocal Microscopy, Imaging, Membrane, Comparison



    Similar Products

    rfp eea1  (Addgene inc)
    93
    Addgene inc rfp eea1
    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker <t>RFP-EEA1</t> and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).
    Rfp Eea1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rfp+eea1/pmc11850004-253-0-21?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    rfp eea1 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    plasmid reference gfp sorla 1 rfp t eea1 2 rfp vps29 3 mcherry rab4 a gift  (Addgene inc)
    93
    Addgene inc plasmid reference gfp sorla 1 rfp t eea1 2 rfp vps29 3 mcherry rab4 a gift
    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker <t>RFP-EEA1</t> and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).
    Plasmid Reference Gfp Sorla 1 Rfp T Eea1 2 Rfp Vps29 3 Mcherry Rab4 A Gift, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rfp+eea1/pmc07892347__41388_2020_1604_MOESM1_ESM-33-0-14?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    plasmid reference gfp sorla 1 rfp t eea1 2 rfp vps29 3 mcherry rab4 a gift - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    eea1-rfp bacmam 2.0  (Thermo Fisher)
    90
    Thermo Fisher eea1-rfp bacmam 2.0
    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker <t>RFP-EEA1</t> and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).
    Eea1 Rfp Bacmam 2.0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rfp+eea1/pmc05941078-283-18-24?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    eea1-rfp bacmam 2.0 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker RFP-EEA1 and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).

    Journal: eLife

    Article Title: Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration

    doi: 10.7554/eLife.99373

    Figure Lengend Snippet: ( A ) Schematic representation of the experimental design used to measure luminescence upon proximity between Rap1GAP-SmBiT and LgBiT-FYVE in response to CCR7 activation. ( B ) Change in luminescence measured upon stimulation of HEK293-CCR7 cells expressing Rap1GAP-SmBiT and LgBiT-FYVE in response to 100 nM CCL19 or 100 nM CCL21 stimulation. The response to chemokine stimulation was normalized to vehicle control. ( C ) Area under the curve (AUC) was used to calculate the total response for each chemokine ligand. Data represent the mean ± SE of N=4 experiments. ( D ) Schematic representation of the enhanced bystander bioluminescence resonance energy transfer (EbBRET)-based assay to monitor proximity between RlucII-miniGi and the endosomal marker rGFP-Rab5 upon CCR7 activation from endosomes. ( E ) EbBRET measurements from CCR7-expressing HEK293 cells co-transfected with RlucII-miniGi and rGFP-Rab5 upon stimulation with 100 nM CCL19, 100 nM CCL21, or vehicle control. Data represents the mean ± SE from N=5 independent experiments. ( F ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the plasma membrane marker RFP-Lck and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 10 min. Representative images from N=3 experiments. ( G ) Co-localization quantification analysis of RFP-Lck and Halo-miniGi from six representative confocal microscopy images per condition. ( H ) Confocal microscopy imaging displaying CCR7-expressing HEK293 cells co-transfected with the endosomal marker RFP-EEA1 and Halo-miniGi. The cells were stimulated with 100 nM CCL19, 100 nM CCL21, or vehicle control for 30 min. Representative images from N=3 experiments. ( I ) Co-localization quantification analysis of RFP-EEA1 and Halo-miniGi from five confocal microscopy images per condition. ( C, E, G, and I ) One-way ANOVA with Tukey’s multiple comparison post hoc tests were applied to determine statistical differences between the distinct treatments (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).

    Article Snippet: RFP-EEA1 (TagRFP-T-EEA1 cloned into pEGFP-C1 vector) and HA-Dyn-K44A (cloned into pcDNA3.1) constructs were gifts from Silvia Corvera and Sandra Schmid (respectively Addgene plasmids #42635 and #34683).

    Techniques: Activation Assay, Expressing, Control, Bioluminescence Resonance Energy Transfer, Marker, Transfection, Confocal Microscopy, Imaging, Membrane, Comparison